Page last updated: 2024-09-03

eth 615 and n-formylmethionine leucyl-phenylalanine

eth 615 has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(eth 615)
Trials
(eth 615)
Recent Studies (post-2010)
(eth 615)
Studies
(n-formylmethionine leucyl-phenylalanine)
Trials
(n-formylmethionine leucyl-phenylalanine)
Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine)
7006,71653356

Protein Interaction Comparison

ProteinTaxonomyeth 615 (IC50)n-formylmethionine leucyl-phenylalanine (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahnfelt-Rønne, I; Jinquan, T; Kristensen, M; Larsen, CG; Matsushima, K; Paludan, K; Thestrup-Pedersen, K; Thomsen, MK; Zachariae, C1

Other Studies

1 other study(ies) available for eth 615 and n-formylmethionine leucyl-phenylalanine

ArticleYear
ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin-8.
    Experimental dermatology, 1993, Volume: 2, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Gene Expression Regulation; Humans; Interleukin-8; Leukotriene B4; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Quinolines; Recombinant Proteins; T-Lymphocytes; Transcription, Genetic

1993